Who owns GYRE THERAPEUTICS INCORPORATED?
- Ticker: GYRE
- CUSIP Number: 403783103
Tip: Access positions for across all investors
Analyze quarterly positions in Gyre Therapeutics Incorporated with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gyre Therapeutics Incorporated stock
Who bought or sold GYRE THERAPEUTICS INCORPORATED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 195k | $3.4M | -2% | Mar 2024 |
|
| BlackRock | 172k | $3.0M | 100% | Mar 2024 |
|
| Geode Capital Management | 161k | $2.8M | 100% | Mar 2024 |
|
| Millennium Management | 60k | $1.1M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 46k | $806k | 100% | Mar 2024 |
|
| State Street Corporation | 41k | $709k | 183% | Mar 2024 |
|
| Jane Street | 31k | $534k | 100% | Mar 2024 |
|
| Marshall Wace | 26k | $447k | 100% | Mar 2024 |
|
| Northern Trust | 24k | $417k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 20k | $347k | 6759% | Mar 2024 |
|
| Balyasny Asset Management | 14k | $244k | 100% | Mar 2024 |
|
| Citigroup | 12k | $213k | 57% | Mar 2024 |
|
| Qube Research & Technologies | 6.2k | $109k | 100% | Mar 2024 |
|
| Morgan Stanley | 5.7k | $100k | 100% | Mar 2024 |
|
| Tower Research Capital | 2.9k | $50k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 718.00 | $13k | 100% | Mar 2024 |
|
| Macquarie Group | 408.00 | $7.017600 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 96.00 | $1.7k | 2% | Mar 2024 |
|
| Old Point Trust & Financial Services N A | 33.00 | $576.998400 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 14.00 | $245.000000 | 0% | Mar 2024 |
|
| Acadian Asset Management | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Gyre Therapeutics Incorporated?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Parallax Volatility Advisers | Dec 2023 | 33k | $848k |
| Renaissance Technologies | Dec 2023 | 17k | $439k |
| UBS Group | Dec 2023 | 333.00 | $8.6k |
| Wetzel Investment Advisors | Dec 2023 | 266.00 | $7.0k |